(Q37283036)

19 August 2017

1 reference

title

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome (English)

1 reference

19 August 2017

0 references

0 references

6

P L Meroni

1 reference

19 August 2017

2

M O Borghi

1 reference

19 August 2017

E Raschi

1

1 reference

19 August 2017

C Grossi

series ordinal

3

1 reference

19 August 2017

V Broggini

series ordinal

4

1 reference

19 August 2017

S Pierangeli

series ordinal

5

1 reference

19 August 2017

language of work or name

1 reference

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

17

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

937-942

1 reference

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Infectious origin of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptors: paving the path to T cell-driven autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptors and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptors in inflammation, infection and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Humoral autoimmunity against endothelium: theory or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Endothelium and the brain in CNS lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Differential binding of ligands to the apolipoprotein E receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

An LDL-receptor-related protein mediates Wnt signalling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptor polymorphisms and susceptibility to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Functions of toll-like receptors: lessons from KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptors in the pathogenesis of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Annexin A2 mediates endothelial cell activation by antiphospholipid/anti- 2 glycoprotein I antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

Anti–β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308095140

21 January 2018

Identifiers

DOI

10.1177/0961203308095140

1 reference

19 August 2017

1 reference